98%
921
2 minutes
20
Angiogenesis, the development of new blood vessels from existing vasculature, is a key process in normal development and pathophysiology. In vitro models are necessary for investigating mechanisms of angiogenesis and developing antiangiogenic therapies. Microfluidic cell culture models of angiogenesis are favored for their ability to recapitulate 3D tissue structures and control spatiotemporal aspects of the microenvironments. To capture the angiogenesis process, microfluidic models often include endothelial cells and a fibroblast component. However, the influence of fibroblast organization on resulting angiogenic behavior remains unclear. Here a comparative study of angiogenic sprouting on a microfluidic chip induced by fibroblasts in 2D monolayer, 3D dispersed, and 3D spheroid culture formats, is conducted. Vessel morphology and sprout distribution for each configuration are measured, and these observations are correlated with measurements of secreted factors and numerical simulations of diffusion gradients. The results demonstrate that angiogenic sprouting varies in response to fibroblast organization with correlating variations in secretory profile and secreted factor gradients across the microfluidic device. This study is anticipated to shed light on how sprouting dynamics are mediated by fibroblast configuration such that the microfluidic cell culture design process includes the selection of a fibroblast component where the effects are known and leveraged.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adbi.202101080 | DOI Listing |
Int Immunopharmacol
September 2025
Center for Genetic Engineering and Biotechnology, Cubanacan, 10600 Havana, POBox 6162, Cuba. Electronic address:
Vascular endothelial growth factor (VEGF) is a key player in the development and progression of several diseases, most notably cancer and retinal disorders. Over the last twenty years, VEGF has emerged as a significant therapeutic target for these conditions. This study reports the isolation and characterization of a fully synthetic, humanized, affinity-matured single-domain antibody fragment (VHH) designed to target VEGF.
View Article and Find Full Text PDFCell Signal
September 2025
School of Optometry and Vision Science, University of New South Wales, Kensington, NSW 2052, Australia. Electronic address:
Vascular endothelial growth factor (VEGF), a pro-angiogenic molecule, supports blood vessel growth during wound healing but also drives pathological neovascularization in blinding eye diseases such as neovascular age-related macular degeneration (nAMD). Dimethyl fumarate (DMFu), an FDA-approved drug for multiple sclerosis, has previously shown promising anti-inflammatory properties in retinal pigment epithelium, a crucial structure disrupted by nAMD. Here, we extend the multi-phenotypic therapeutic potential of DMFu by discerning the anti-angiogenic capabilities of DMFu in choroidal and retinal endothelial cells.
View Article and Find Full Text PDFJ Clin Invest
August 2025
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America.
Peripheral artery disease (PAD) often advances to chronic limb-threatening ischemia (CLTI), resulting in severe complications such as limb amputation. Despite the potential of therapeutic angiogenesis, the mechanisms of cell-cell communication and transcriptional changes driving PAD are not fully understood. Profiling long non-coding RNAs (lncRNAs) from gastrocnemius muscles of human subjects with or without CLTI revealed that a vascular smooth muscle cell (SMC)-enriched lncRNA CARMN, was reduced with CLTI.
View Article and Find Full Text PDFMethods Mol Biol
August 2025
Department of Physiology & Neurobiology, University of Connecticut, Storrs, CT, USA.
The mouse retina is a widely used model to study sprouting angiogenesis. Most blood vessel staining protocols focus on the superficial vascular layer. Here, we describe a method to obtain thick sections of retina whole-mounts that allow for detailed visualization of diving vascular sprouts, and deep and intermediate-layer angiogenesis.
View Article and Find Full Text PDFMethods Mol Biol
August 2025
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
We describe here how to prepare and analyze serum-free cultures of mouse aortic rings for the study of angiogenesis. Removal of serum from the culture medium helps visualize angiogenic neovessels by reducing fibroblast outgrowth and allows evaluation of test substances without interference by serum molecules. Mouse aortic rings are, however, unable to sprout using the serum-free method originally developed for the rat aortic ring assay, unless stimulated with exogenous angiogenic factors.
View Article and Find Full Text PDF